Partial least squares Discriminant analysis on MS studies

This analysis uses the "muma" package of the R statistics environment (Reference)

Click on links below to perform analysis.

PLSDA	Study ID	Scaling	Study Title	MS Analysis Type
	ST002011	Auto Pareto Vast Median Range None	The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases.	Reversed phase NEGATIVE ION MODE
	ST002011	Auto Pareto Vast Median Range None	The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases.	Reversed phase NEGATIVE ION MODE
	ST002011	Auto Pareto Vast Median Range None	The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases.	Reversed phase NEGATIVE ION MODE